HealthNotableCorroboratingDeveloping
5.5
Unapproved weight-loss drug Retatrutide linked to rising hospitalizations
RTÉLO·IE·1 day ago
Clinical data indicates that metabolic individuality—comprising genetic, hormonal, and behavioral factors—explains disparate weight loss outcomes among patients with similar profiles. This variability complicates standardized treatment efficacy in Brazil, where over 60% of the population is overweight.
Locations
Entities